Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00871936 · ClinicalTrials.gov registry record · Phase 2

A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes

A Phase 2 study of Type 2 Diabetes, sponsored by Response Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
82
Enrollment target
12
Study locations

NCT00871936 is a Phase 2 study of Type 2 Diabetes that has completed, run by Response Pharmaceuticals. The registered enrollment target is 82 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (93% lower). The trial reports 12 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00871936, a Phase 2 study of Type 2 Diabetes, has completed, sponsored by Response Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
82 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this study is to determine whether SLx-4090 in combination with metformin therapy will reduce HbA1c in patients with Type 2 Diabetes more effectively than metformin therapy alone.

Conditions Studied

Type 2 Diabetes

Interventions

  • OTHER Placebo
  • DRUG Metformin
  • DRUG SLx-4090

Study Locations (12)

California

  • - Anaheim
  • - Burbank
  • - Los Angeles
  • - Los Angeles

North Carolina

  • - Charlotte
  • - Hickory
  • - Winston-Salem

Florida

  • - West Palm Beach

Illinois

  • - Addison

Maine

  • - Auburn

South Carolina

  • - Greenville

Texas

  • - San Antonio

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2009-04
Est. Completion 2009-10
Phase Phase 2

Sponsor

Response Pharmaceuticals

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00871936

The ClinicalTrials.gov registry entry for NCT00871936 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is Response Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00871936 reports 12 study locations spanning 7 distinct geographic areas - top geographies include California, North Carolina, Florida.

Frequently Asked Questions

What is clinical trial NCT00871936 about?

NCT00871936 is a clinical study titled "A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes". The purpose of this study is to determine whether SLx-4090 in combination with metformin therapy will reduce HbA1c in patients with Type 2 Diabetes more effectively than metformin therapy alone.

What is the current status of trial NCT00871936?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 82 participants. The study started on 2009-04. Estimated completion is 2009-10.

What conditions does trial NCT00871936 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT00871936?

The interventions under investigation include: Placebo (OTHER), Metformin (DRUG), SLx-4090 (DRUG).

Who is sponsoring clinical trial NCT00871936?

This trial is sponsored by Response Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00871936 being conducted?

This trial has 12 study locations across California, Florida, Illinois, Maine, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.